William Plovanic
Stock Analyst at Canaccord Genuity
(3.61)
# 768
Out of 4,840 analysts
130
Total ratings
44.44%
Success rate
7.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $115 → $101 | $91.67 | +10.18% | 3 | May 12, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $152 → $139 | $142.44 | -2.42% | 10 | May 2, 2025 | |
| DXCM DexCom | Maintains: Buy | $103 → $106 | $84.83 | +24.96% | 6 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $20.64 | +185.85% | 4 | May 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $71 → $75 | $74.79 | +0.28% | 26 | Apr 25, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $6.65 | +170.68% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $5.51 | +99.64% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $32.78 | +58.63% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $123.34 | -15.68% | 5 | Mar 11, 2025 | |
| STIM Neuronetics | Maintains: Buy | $5 → $8 | $3.99 | +100.50% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $17.26 | +91.19% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $101 | $58.60 | +72.35% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $321.00 | -5.30% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $104.50 | -3.35% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $6.51 | +130.41% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $9.40 | +27.66% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $266.75 | +6.47% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $12.48 | +100.32% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $3.12 | +284.62% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $95.11 | -26.40% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $18.76 | +155.86% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.13 | +432.69% | 3 | Jul 25, 2023 |
Zimmer Biomet Holdings
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $91.67
Upside: +10.18%
iRhythm Technologies
May 2, 2025
Maintains: Buy
Price Target: $152 → $139
Current: $142.44
Upside: -2.42%
DexCom
May 2, 2025
Maintains: Buy
Price Target: $103 → $106
Current: $84.83
Upside: +24.96%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $20.64
Upside: +185.85%
Edwards Lifesciences
Apr 25, 2025
Maintains: Hold
Price Target: $71 → $75
Current: $74.79
Upside: +0.28%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $6.65
Upside: +170.68%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.51
Upside: +99.64%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $32.78
Upside: +58.63%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $123.34
Upside: -15.68%
Neuronetics
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $3.99
Upside: +100.50%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $17.26
Upside: +91.19%
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $58.60
Upside: +72.35%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $321.00
Upside: -5.30%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $104.50
Upside: -3.35%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $6.51
Upside: +130.41%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.40
Upside: +27.66%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $266.75
Upside: +6.47%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $12.48
Upside: +100.32%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $3.12
Upside: +284.62%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $95.11
Upside: -26.40%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $18.76
Upside: +155.86%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.13
Upside: +432.69%